Chemotherapy Clinical Trials in Wuhan, Hubei
5 recruitingWuhan, Hubei, China
Showing 1–5 of 5 trials
Recruiting
Phase 2
A Pilot Study Evaluating β-hydroxybutyrate Supplementation Concomitant to Short-Course Radiotherapy Followed by Immunotherapy Combined With CAPEOX Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer
ChemotherapyRectal CancerRadiotherapy+1 more
Tao Zhang25 enrolled1 locationNCT07239466
Recruiting
Phase 4
Firmonertinib Combined With Intrathecal Injection for the Treatment of EGFR Mutant NSCLC With Leptomeningeal Metastases
NSCLCLeptomeningeal MetastasisTyrosine Kinase Inhibitor+1 more
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology40 enrolled1 locationNCT07092202
Recruiting
Deep Learning Model Predicts Pathological Complete Response of Esophageal Squamous Cell Carcinoma Following Neoadjuvant Immunochemotherapy
Esophageal Squamous Cell CarcinomaPathological Complete ResponseDeep Learning+1 more
Tongji Hospital300 enrolled1 locationNCT07088354
Recruiting
Not Applicable
Effect of Adding Electroacupuncture to Anti-cancer Therapy-induced Peripheral Neuropathy
CancerChemotherapy-induced Peripheral Neuropathy (CIPN)
Zhongnan Hospital150 enrolled1 locationNCT06858709
Recruiting
Not Applicable
Ondanstron Weekly vs Every 3 Weeks for Prevention of Nausea and Vomiting Induced by Chemotherapy Combined With PD-1 Blockade
Nausea With Vomiting Chemotherapy-Induced
Hubei Cancer Hospital98 enrolled1 locationNCT06080880